84 results match your criteria: "Centre de Rein Artificiel[Affiliation]"

Silicone catheter (C) can be used in the hemodialysis setting as an alternative for the blood access. We analysed retrospectively the 3 types of the catheters used in 45 patients. 58 catheters were percutaneously inserted in the internal jugular vein (9 Bard (B)-Hickman; 17 Canaud (CD)-Vygon; 32 Permcath (PC)-Quinton).

View Article and Find Full Text PDF

The functional survival of the same silicone double lumen catheter (DLC) was analyzed in relation with the mode of its insertion. Thirty-seven catheters were surgically inserted (34 in the right internal Jugular vein, 3 in the left internal Jugular vein), while 28 were percutaneously inserted (25 in the right internal Jugular vein, 3 in the left internal Jugular vein). The functional survival was calculated using Kaplan Meier method.

View Article and Find Full Text PDF

Hypertension is a major cause of mortality and morbidity in hemodialysis patients. A long slow dialysis (8 h/session) was used in 692 unselected patients. It allowed for an excellent control of blood pressure without the need of antihypertensive medications.

View Article and Find Full Text PDF

Sixty-six haemodialysed (HD) in centre patients (24 h/m2/week, acetate bath, cuprophane membrane), with a mean age of 59.2 years, treated for 16.7 +/- 4.

View Article and Find Full Text PDF

To examine how patient survival substantiates dialysis adequacy, 20-year actuarial survival experience was calculated for 445 unselected hemodialysis (HD) patients (97 patients accepted on a temporary basis--and usually kept on their regular dialysis scheme--were left out). The dose of dialysis has been the same and unchanged for all patients since beginning: 24 square meter hours of Kiil dialysis (cuprophane) per week with acetate buffered dialysate. KT/V mean (SD) was 1.

View Article and Find Full Text PDF

Wider patient acceptance criteria in hemodialysis (HD) programs do not seem to completely explain the increasing mortality reported in the United States at a time characterized by reduced treatment time and dose. This raises the question of HD standard and adequacy. It stimulated us to analyze patient survival with unchanged 'old-times' methods.

View Article and Find Full Text PDF